ARCHIVES

FDA Official Outlines agency’s Views On Efficacy Requirement

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Argentine Human Rights Violations Continue, But Some Improvement Seen

October 20, 1978

NIH And E.I. Dupont Sign OncoMouse Agreement.

January 28, 2000

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

NCI-Approved Clinical Trials

December 31, 2004

CCOP RFA Due In Mid-July; DCT Board Gives Its Concept Approval

June 11, 1982

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009